VLA
Click for more information
0.00% $1.75 viralytics limited

Gilead buys Kite Pharma for $11.9 BN, page-23

  1. Lopez
    12,221 Posts.
    lightbulb Created with Sketch. 1087
    clock Created with Sketch.
    06/09/17
    14:22
    Post #: 27035250
    Hi ,
    Interesting the FDA are on Mercks case for patient deaths in their combination trials.
    With Cavatak it's next to none for adverse affects.
    More on Fiercepharma if interested.
    Aloha.
    VLA Price at posting: 90.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

1CG OneClick surpasses 150,000 registered users
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board
right-arrow Created with Sketch.
SKC SkyCity to lose NZ$5M in 2025 over complaint closedown
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.